Xconomy

FEBRUARY 7, 2019

Gossamer Bio, the San Diego-based biotech founded by former Receptos executives, has raised $276 million in its initial public offering, a total that puts it in a rare class among biotechs that have gone public in recent years. The amount raised surpassed expectations.

San Diego 99

San Diego Class Pricing Marketing 99

Xconomy

MARCH 1, 2019

In this Xconomy Special Report, our veteran biotech journalists Alex Lash and Ben Fidler bring you deep insights, based on conversations with key industry leaders, on what 2019 and beyond hold for biopharmaceutical companies. After years of boom times, the U.S.

Report 83

Report Pricing Sales San Diego 83

Xconomy

AUGUST 11, 2020

San Diego-based Ligand (NASDAQ: LGND ) generates revenue from licensing deals and royalties paid by pharmaceutical companies that use technologies it develops or acquires for their own drug research. million in 2019. The company reported revenues of about $120.3

San Diego 98

San Diego Technology Research Pricing 98

Xconomy

DECEMBER 26, 2018

software startups to reflect on the trends that defined the sector in 2018—and where things might be headed in 2019. As part of Xconomy’s series of year-end posts , we asked a pair of CEOs of Boston-area A.I. Here are their comments, shared via e-mail: — Rana el Kaliouby , CEO and co-founder of Affectiva : At.

Artificial Inteligence 94

Artificial Inteligence Venture Capital Research Acquisition 94

Xconomy

JANUARY 30, 2019

But a 2019 that started with stock market losses, a recently ended (but longest-ever) government shutdown, and other headwinds might now force consumers to pull back on spending. The big question is what’s going to happen with the economy,” says Michelle Bacharach, founder and CEO of FindMin e.

Marketing 67

Marketing Customer Custom Technology 67

Xconomy

APRIL 27, 2020

The San Diego-based biotech, which started operations about 18 months ago, made its public debut in December 2018 with $42 million. In March 2019 it extended the Series A, tacking on $22 million more. Read more » Reprints | Share:

San Diego 76

San Diego Entrepreneur Develop Development 76

Xconomy

JANUARY 28, 2019

Scott Beechuk, a partner at Norwest Venture Partners , is one of the tech industry observers invited by Xconomy to look back at the technology developments of 2018, and also forecast some trends he expects to see in 2019. Palo Alto, CA-based Norwest weathers the uncertainties of technology and the economy with an investing strategy.

Venture Capital 67

Venture Capital Marketing Guide Invest 67

Xconomy

DECEMBER 3, 2018

The acquisition, which is expected to close by the end of March 2019, continues San Diego-based ResMed’s (NYSE: RMD ) “connected healthcare” push that began about five years ago, as Xconomy chronicled last year. [ Updated 12/3/18, 3:30 pm, with CEO comments.

San Diego 93

San Diego Acquisition Capital Help 93

Xconomy

JANUARY 13, 2020

The division of San Diego-based Human Longevity generated approximately $10 million in revenue in 2019—an amount NeoGenomics (NASDAQ: NEO ) thinks it can grow by nearly 50 percent, says Charlie Eidson, investor relations and corporate development analyst, NeoGenomics.

San Diego 63

San Diego Outsource Development Services Develop 63

Xconomy

APRIL 23, 2019

After a breakout year in 2017, the blockchain sector suffered a series of blows in 2018, from crashing cryptocurrency prices to increased regulatory scrutiny of crypto ventures and deepening skepticism about whether the technology was actually useful.

Report 98

Report Pricing Organization Technology 98

Xconomy

SEPTEMBER 10, 2019

This year’s Lasker Awards, the US’s most prestigious biomedical honor, are going to five scientists whose work led to a critical breast cancer treatment and significant basic research advances that have helped pave the way for immunotherapy.

Research 98

Research Help San Diego Blogging 98

Xconomy

MAY 15, 2019

Austin —MassChallenge has picked the 74 early-stage companies that will eventually compete for a portion of $500,000 in cash as a part of its Austin accelerator program. They’re startups that are developing products in a wide range of sectors, including life sciences, agriculture, and artificial intelligence.

Artificial Inteligence 82

Artificial Inteligence Startup Funding Product 82

Xconomy

OCTOBER 1, 2019

The European Society for Medical Oncology meeting has wrapped up in Barcelona, the last major clinical cancer conference until December’s annual ASH meeting for blood diseases. We’ve highlighted a few top stories for you.

Class 88

Class Conference News San Diego 88

Xconomy

JUNE 5, 2019

The American Society of Clinical Oncology meeting in Chicago has wrapped up for another year.

Develop 97

Develop Development Study San Diego 97

Xconomy

APRIL 3, 2019

[ Editor’s note: Alex Lash co-authored this report ] The American Association for Cancer Research’s annual meeting is wrapping up in Atlanta today.

Conference 107

Conference Startup Research News 107

Xconomy

DECEMBER 21, 2018

It’s beginning to look a lot like, well, the last roundup of the year, with plenty of news to pack in before our holiday breather.

Pricing 73

Pricing Sales Study News 73

Xconomy

OCTOBER 23, 2018

Ed Kaye stepped aside from Sarepta Therapeutics (NASDAQ: SRPT ) last year after leading the company through one of the most noteworthy and controversial drug approvals in recent memory, for the Duchenne muscular dystrophy drug eteplirsen (Exondys 51). But his hiatus from a publicly traded biotech could be short-lived.

Funding 101

Funding Startup Help Develop 101

socalTECH

DECEMBER 26, 2018

In my new role as the first executive director for the Alliance for Southern California Innovation, I spent a lot of time outside of my home turf of Pasadena -- visiting innovation nodes such as San Diego, Irvine, Riverside, Santa Barbara, Venice, Santa Monica, and others.

Southern California 113

Southern California SoCal Pasadena Startup 113

Xconomy

JUNE 25, 2019

Even as Uber, Lyft, and other high-profile initial public offerings underperformed out of the gate, the average share price of companies that have gone public in the US this year is up by almost 33 percent.

Startup 69

Startup Pricing Company Companies 69

Xconomy

DECEMBER 18, 2018

Disease area : Nonalcoholic steatohepatitis (NASH) Companies : Intercept Pharmaceuticals, Genfit Trial : REGENERATE , RESOLVE-IT Data expected : 1H 2019 (REGENERATE), 2H 2019 (RESOLVE-IT) Why We’re Watching : Sometimes diseases are. Read on for the details. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Study 83

Study Report San Diego Company 83

Xconomy

JULY 17, 2020

This week they released their quarterly analysis of dealmaking, which shows that the tally of big biotech transactions tops the second quarter of 2019 when biotech and pharmaceutical investments accounted for just 10 of the top 25 deals. The figures come from the National Venture Capital Association and financial research firm Pitchbook.

Venture Capital 90

Venture Capital Invest Research Capital 90

Xconomy

MAY 9, 2019

To date in 2019, 23 healthcare-related companies have gone public, the most of any sector. According to IPO research firm Renaissance Capital , 47 IPOs have priced so far this year across all sectors, down 27 percent compared to the same period in 2018. Just as last year, healthcare IPOs lead the way. Here’s a look.

Pricing 110

Pricing Research Capital Marketing 110

Xconomy

JANUARY 2, 2019

So, you might imagine that his outlook on data protection for 2019 would be more optimistic than in past years, because businesses now take advantage of a broad choice of security services to protect themselves. Bob Ackerman is one of the venture capitalists whose funding has long fed the growth of the burgeoning cybersecurity industry.

Venture Capital 110

Venture Capital Funding Services Startup 110

Xconomy

APRIL 12, 2019

The deal should close in the third quarter of 2019. Bristol (NYSE: BMY ) said Friday that more than 75 percent of its shareholders voted to approve the deal at a meeting on Friday. Some 98 percent (NASDAQ: CELG ) of Celgene’s stockholders supported the deal, the company said in a separate announcement.

Organization 98

Organization San Diego Company Companies 98

Xconomy

SEPTEMBER 25, 2019

The total for the first three quarters of 2019 was about $8 billion shy of. Collectively these businesses raised about $44 billion in their debuts, topping the $34 billion, $21 billion, and $40 billion raised in 2015, 2016, and 2017, respectively. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Activity 81

Activity Report News Marketing 81

Xconomy

OCTOBER 7, 2019

But the work to understand how cells sense and adapt to changes in oxygen levels has led to medical insights and potential treatments for anemia, cancer, and more—and today, it has turned into the 2019 Nobel Prize in Medicine. William Kaelin Jr.,

Study 80

Study Activity San Diego Blogging 80

Xconomy

NOVEMBER 8, 2018

Earlier this month, GM CEO Mary Barra told the crowd at a financial conference that her company was on track to unveil a ridesharing service in 2019 that would be powered by autonomous vehicles.

Framework 95

Framework Mobile Conference News 95

Xconomy

JANUARY 10, 2019

The market caps of some of the most successful tech titans reach as high as $1 trillion. Yet in 2018, perceptions about these dominant companies often reflected uneasiness and doubt—and for some, so did their stock performance.

Platform 43

Platform Marketing Company Companies 43

Xconomy

OCTOBER 3, 2018

Palo Alto, CA-based Cloudera (NYSE: CLDR ) and Santa Clara, CA-based Hortonworks (NASDAQ: HDP ) said they expect the merger to close during the first quarter of 2019 if it passes an antitrust review. The goal of the combined entity is to provide a leading data platform. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Platform 93

Platform Software Review Web Pricing 93

Xconomy

DECEMBER 17, 2018

[ Editor’s note: This is part of a series of posts sharing thoughts from technology leaders about 2018 trends and 2019 forecasts. Today’s artificial intelligence technologies have demonstrated they’re capable of handling specific tasks, such as identifying pictures of cats or spotting cancer in CT scans.

Artificial Inteligence 88

Artificial Inteligence IBM IBM Training 88

Xconomy

JANUARY 2, 2019

companies such as Brainspace and Hypergiant Sensory Sciences, the pace of adoption will only accelerate in 2019. The promise, and pitfalls, of artificial intelligence became more apparent in the last year, and for Dave Copps, founder of A.I.

Artificial Inteligence 80

Artificial Inteligence Web Tool Help 80

Xconomy

FEBRUARY 12, 2018

” Today, his administration’s fiscal 2019 budget proposal laid out what it calls a “comprehensive” strategy to lower drug prices. As president-elect, Donald Trump in January 2017 slammed drug companies for “getting away with murder” and said he supported Medicare negotiation.

Pricing 84

Pricing Product San Diego Company 84

Xconomy

JANUARY 3, 2020

For what it’s worth, the FDA didn’t say how many drugs it rejected in 2019 but the final week of the year included one such denial. Most of the nods went to small molecule drugs and cancer drugs continued to represent a significant chunk of the new approved medicines. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 57

San Diego Blogging Invest Startup 57

Xconomy

JANUARY 4, 2019

What will make our Best of 2019 list? Topics ranged from the worries over CRISPR genome editing and Wild West biohacking, to Nobel Prize-fueled drug approvals and the headaches around drug prices (even for drugs meant to cure headaches). Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Pricing 69

Pricing Email Networking Silver Lake 69

Xconomy

JANUARY 15, 2019

As Xconomy’s editors looked back at the year just passed, we asked technology leaders to comment on the trends they’d observed in 2018, and the developments they expected in 2019.

.Net 65

.Net Technology Develop Development 65

Xconomy

JULY 30, 2019

On Monday, Illumina (NASDAQ: ILMN ) informed the markets that it had overshot the mark with its 2019 estimates. It exceeded that goal, with revenue rising 21 percent to $3.33 billion by the end of 2018. It’s a different financial story this summer.

Study 59

Study News Demand Tool 59

Xconomy

JANUARY 24, 2019

But looking back from the viewpoint of 2019, it’s worth considering whether the really pivotal, world-changing advances in transportation have not already been launched. It came in relatively quick steps: —The first time a person with a smartphone stepped into a car, that vehicle became, by proxy, a connected device with GPS.

Mobile 48

Mobile Outsource Development Artificial Inteligence Venture Capital 48